Detalles de la búsqueda
1.
Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort study.
Respirology
; 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654512
2.
Real-world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive non-small-cell lung cancer.
Cancer Sci
; 114(6): 2560-2568, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36866958
3.
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib.
Cancer Sci
; 114(2): 606-618, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36169649
4.
Health Care Resource Use Among Patients with Advanced Non-Small Cell Lung Cancer in Japan, 2017-2019.
Curr Ther Res Clin Exp
; 99: 100712, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37519418
5.
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a "tail plateau" in the survival curve of these patients?
BMC Cancer
; 22(1): 323, 2022 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35337281
6.
Efficacy of platinum agents for stage III non-small-cell lung cancer following platinum-based chemoradiotherapy: a retrospective study.
BMC Cancer
; 22(1): 342, 2022 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35351059
7.
Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study.
BMC Cancer
; 22(1): 1047, 2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203123
8.
Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.
Cancer Sci
; 112(10): 4393-4403, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34310819
9.
A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients.
Cancer Sci
; 111(5): 1685-1691, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32103551
10.
Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.
Oncologist
; 25(4): e668-e674, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31771990
11.
Hermansky-Pudlak syndrome-associated pneumothorax with rapid progression of respiratory failure: a case report.
BMC Pulm Med
; 20(1): 259, 2020 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33023548
12.
Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan.
Jpn J Clin Oncol
; 49(1): 63-68, 2019 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30452719
13.
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial.
Lancet
; 390(10089): 29-39, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28501140
14.
Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
Oncologist
; 23(10): 1210-1217, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567820
15.
Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study.
BMC Cancer
; 17(1): 302, 2017 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28464801
16.
Cerebral infarction in advanced non-small cell lung cancer: a case control study.
BMC Cancer
; 16: 203, 2016 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26964872
17.
Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 16(16): 1630-8, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26522337
18.
The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patients.
Invest New Drugs
; 33(3): 755-60, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25846908
19.
Multicenter observational cohort study of post-operative treatment for completely resected non-small-cell lung cancer of pathological Stage I (T1 >2 cm and T2 in TNM classification version 6).
Jpn J Clin Oncol
; 45(5): 499-501, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25724215
20.
Corrigendum to: Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan.
Jpn J Clin Oncol
; 50(4): 481, 2020 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32065232